Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10)
- PMID: 2933464
Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10)
Abstract
Reconstitution of lethally irradiated mice with a mixture of T cell-depleted syngeneic plus T cell-depleted allogeneic bone marrow (B10 + B10.D2----B10) leads to the induction of mixed lymphopoietic chimerism, excellent survivals, specific in vivo transplantation tolerance to subsequent donor strain skin grafts, and specific in vitro unresponsiveness to allogeneic donor lymphoid elements as assessed by mixed lymphocyte reaction (MLR) proliferative and cell-mediated lympholysis (CML) cytotoxicity assays. When B10 recipient mice received mixed marrow inocula in which the syngeneic component had not been T cell depleted, whether or not the allogeneic donor marrow was treated, they repopulated exclusively with host-type cells, promptly rejected donor-type skin allografts, and were reactive in vitro to the allogeneic donor by CML and MLR assays. In contrast, T cell depletion of the syngeneic component of the mixed marrow inocula resulted in specific acceptance of allogeneic donor strain skin grafts, whether or not the allogeneic bone marrow was T cell depleted. Such animals were specifically unreactive to allogeneic donor lymphoid elements in vitro by CML and MLR, but were reactive to third party. When both the syngeneic and allogeneic marrow were T cell depleted, variable percentages of host- and donor-type lymphoid elements were detected in the mixed reconstituted host. When only the syngeneic bone marrow was T cell depleted, animals repopulated exclusively with donor-type cells. Although these animals had detectable in vitro anti-host (B10) reactivity by CML and MLR and reconstituted as fully allogeneic chimeras, they exhibited excellent survival and had no in vivo evidence for graft-vs-host disease. In addition, experiments in which untreated donor spleen cells were added to the inocula in this last group suggest that the presence of T cell-depleted syngeneic bone marrow cells diminishes graft-vs-host disease and the mortality from it. This system may be helpful as a model for the study of alloresistance and for the identification of syngeneic cell phenotypes, which when present prevent engraftment of allogeneic marrow.
Similar articles
-
Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.Transplantation. 1991 Jun;51(6):1262-7. doi: 10.1097/00007890-199106000-00022. Transplantation. 1991. PMID: 1828637
-
A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.J Immunol. 1995 Nov 1;155(9):4179-88. J Immunol. 1995. PMID: 7594573
-
Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.Transplantation. 1995 Nov 15;60(9):971-80. Transplantation. 1995. PMID: 7491703
-
Achieving alloengraftment without graft-versus-host disease: approaches using mixed allogeneic bone marrow transplantation.Bone Marrow Transplant. 1988 Sep;3(5):379-86. Bone Marrow Transplant. 1988. PMID: 3056545 Review.
-
Hematopoietic cell transplantation for the induction of allo- and xenotolerance.Clin Transplant. 1996 Aug;10(4):357-63. Clin Transplant. 1996. PMID: 8884109 Review.
Cited by
-
Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants.Am J Transplant. 2012 May;12(5):1133-45. doi: 10.1111/j.1600-6143.2012.03992.x. Epub 2012 Mar 8. Am J Transplant. 2012. PMID: 22405058 Free PMC article.
-
Stable mixed donor-donor chimerism after double cord blood transplantation.Int J Hematol. 2009 Nov;90(4):526-531. doi: 10.1007/s12185-009-0398-y. Epub 2009 Aug 22. Int J Hematol. 2009. PMID: 19697099
-
Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.J Exp Med. 1989 Jan 1;169(1):213-38. doi: 10.1084/jem.169.1.213. J Exp Med. 1989. PMID: 2642528 Free PMC article.
-
Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells.J Exp Med. 1988 Dec 1;168(6):2391-6. doi: 10.1084/jem.168.6.2391. J Exp Med. 1988. PMID: 3264329 Free PMC article.
-
In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment.J Exp Med. 1990 Mar 1;171(3):645-58. doi: 10.1084/jem.171.3.645. J Exp Med. 1990. PMID: 2307931 Free PMC article.
MeSH terms
LinkOut - more resources
Other Literature Sources